Results 271 to 280 of about 412,950 (283)

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Markus Raderer, Barbara Kiesewetter, Andrés J M Ferreri   +2 more
exaly  

Nanomicelle‐Assisted Targeted Ocular Delivery with Enhanced Antiinflammatory Efficacy In Vivo

Advanced Science, 2018
Xing-jie Liang
exaly  

Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface

Allergy: European Journal of Allergy and Clinical Immunology, 2012
Andrea Leonardi, Marek L Kowalski, Pascal Demoly   +2 more
exaly  

Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset

Immunology, 2020
Jeremías G Galletti, Mauricio Guzmán, Joe C Campbell   +2 more
exaly  

Ocular toxoplasmosis II: clinical features, pathology and management

Clinical and Experimental Ophthalmology, 2013
João M Furtado, Justine R Smith
exaly  

The Challenges and Promise of Complement Therapeutics for Ocular Diseases

Frontiers in Immunology, 2019
Dong Ho Park, Kip M Connor, John D Lambris   +2 more
exaly  

Advanced drug delivery and targeting technologies for the ocular diseases

BioImpacts, 2016
Yadollah Omidi, Ayuob Aghanejad, Marziyeh Fathi   +2 more
exaly  

Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions

Journal of Pathology, 2006
Chun-te Wu
exaly  

Fundamentals, challenges, and nanomedicine‐based solutions for ocular diseases

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2019
Dadi A Srinivasarao, Dhirendra S Katti
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly